MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
about
Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancersTargeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectivesRecent progress toward epigenetic therapies: the example of mixed lineage leukemiaHijacked in cancer: the KMT2 (MLL) family of methyltransferasesPotent inhibition of DOT1L as treatment of MLL-fusion leukemiaHigh-affinity, small-molecule peptidomimetic inhibitors of MLL1/WDR5 protein-protein interactionThe super elongation complex (SEC) and MLL in development and disease.Targeted Disruption of the Interaction Between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase ComplexesA SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesisMll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemiasThe rate of spontaneous mutations in human myeloid cellsMenin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemiaKnockdown of menin affects pre-mRNA processing and promoter fidelity at the interferon-gamma inducible IRF1 geneMolecular basis of the mixed lineage leukemia-menin interaction: implications for targeting mixed lineage leukemias.Murine models of acute leukemia: important tools in current pediatric leukemia research.Menin/PRMT5/hedgehog signaling: a potential target for the treatment of multiple endocrine neoplasia type 1 tumors.Chromatin modifications as therapeutic targets in MLL-rearranged leukemia.Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domainMultiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesisPAFc, a key player in MLL-rearranged leukemogenesis.The molecular mechanics of mixed lineage leukemia.Tumor suppressor menin represses paired box gene 2 expression via Wilms tumor suppressor protein-polycomb group complexTargeting β-catenin signaling for therapeutic intervention in MEN1-deficient pancreatic neuroendocrine tumours.MLL becomes functional through intra-molecular interaction not by proteolytic processingTwo decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.Selective targeting of histone methylationIdentification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemiaDOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesisChallenges and opportunities in targeting the menin-MLL interaction.Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?ECSASB2 mediates MLL degradation during hematopoietic differentiationDesign of a fluorescent ligand targeting the S-adenosylmethionine binding site of the histone methyltransferase MLL1.The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential.Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyondThe pathogenesis of mixed-lineage leukemia.EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.MLL leukemia induction by genome editing of human CD34+ hematopoietic cells.
P2860
Q24294703-7EC3755A-7FA7-405A-B947-CCB54BBD0E2BQ24605342-5C53C8DC-DC73-4C58-AA63-3071D54D2D93Q26744441-4AAB3F93-737E-4D94-ABF4-56E7A617D1A7Q26863577-7BDCCC86-B70B-429D-A420-3707F372D412Q27006839-3D345CFB-E0E3-4FD5-9610-290739FE91B6Q27678800-A1DEAAB0-1A8F-4C4F-94D1-2FE6E11F455EQ27683539-B10FF486-6E51-4C9E-B8D3-860B818FC779Q27692038-768556C4-732C-44FD-9740-484159F40A83Q27727739-1D7774B0-2947-4633-B346-CCB5600ADD8FQ28298834-99725A53-8CA1-447B-852E-C1AF8F0C9018Q28594733-C28ABBCE-08F3-4192-A824-458B0B44A129Q28645706-A0E892FC-C59D-42C5-ACAD-9FF0F8C04246Q30425903-7EEFA3AE-BB98-429D-B5DB-53CE6A4987DCQ30428436-00FD0204-BBF8-41A4-9B2D-6CB7F85C3E19Q30429228-9A751BC0-FE74-445A-A172-9E64963FB469Q33606018-BB48A337-5E1F-43DF-9F36-D0679E746621Q33661322-25968228-0E6C-4DA7-928C-4B34AABD38FEQ33666543-E2D31C02-15F2-4F36-86E5-8900333B27FDQ33716402-5B3F68D5-7DA8-4337-8D83-2C5214AB853EQ33761102-D2560665-130B-4903-B7BA-7C621CA87F80Q33987248-700A570B-EBED-4C8B-B38A-E077759CF190Q34245737-0B60594A-FF18-48C4-B067-372309480A4BQ34516051-527DD43B-F131-4792-9170-9EE2A9568B50Q34799923-FB775CFB-05E6-4F15-AABF-329CDCAD5C36Q34832999-E36E3376-A83E-4383-B540-998463868FC5Q34989041-2E4F8D10-0D15-44B1-A7BA-DAF02EC35E58Q35018755-BAA97983-6B7E-4FC8-A3C5-A3A37A5D7F7AQ35045315-4B269ED2-4A49-44A0-BBE1-A81C206024A3Q35056301-CCA4D3F8-2CDB-4010-8979-715C3BC1ECB4Q35083276-5AD32384-D5D1-4C48-BBA9-BDF1633A1FFEQ35122366-1E78277F-5905-4B99-B572-DB9661846C44Q35183855-BD3A4EF6-6D70-40AD-ABFD-476A20E22656Q35687836-C173325E-E27D-4DA0-9609-BE8D28E12379Q35750333-28DEAC29-1CE3-442E-A034-F0809C9ACFB7Q35833904-614A90BD-3EFC-4575-B2C6-DF3435ABBA4EQ35952196-E10B1392-3C1A-4F24-A0CA-8074605C0BFCQ35967446-A4865A98-E3F0-4D07-90A2-3401AB246ABCQ36052947-0B58B49D-CEC0-4B6D-9B63-915B909E2B8CQ36057626-82EE7487-5D1A-4A9C-8FD5-E6D943E19DEBQ36115756-559E299C-EAD6-4445-875F-7D96B321BAFE
P2860
MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
@ast
MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
@en
type
label
MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
@ast
MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
@en
prefLabel
MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
@ast
MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
@en
P2093
P2860
P1433
P1476
MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele
@en
P2093
Austin T Thiel
Danielle Feather
Gary A Koretzky
Peter Blessington
Xianxin Hua
Xinjiang Wu
P2860
P304
P356
10.1016/J.CCR.2009.12.034
P577
2010-02-01T00:00:00Z